Raymond Dwek is Director at UNITED THERAPEUTICS CORP (UTHR). They have made 17 open-market trades across 1 company since 2007, most recently 2025-04-21.
CIK 0001231617
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 17 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| UTHR | 4,750 | $2.9M |
Shares reported on the most recent Form 4, priced at the 2025-04-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| UTHR | SELL · 10b5-1 | 2025-04-21 | 2025-04-22 | $285.57 | $857K | -0.3% | +4.4% | -0.8% |
| UTHR | SELL · 10b5-1 | 2025-04-14 | 2025-04-15 | $285.16 | $1.7M | +3.9% | +6.3% | +4.1% |
| UTHR | SELL · 10b5-1 | 2025-04-07 | 2025-04-08 | $284.55 | $1.1M | +3.2% | +11.8% | +5.4% |
| UTHR | SELL | 2024-08-02 | 2024-08-05 | $325.35 | $1.6M | -0.9% | +8.4% | +15.6% |
| UTHR | SELL | 2022-07-11 | 2022-07-11 | $241.29 | $1.0M | -6.3% | -8.3% | -14.7% |
| UTHR | SELL | 2021-06-29 | 2021-06-30 | $176.01 | $1.2M | +2.0% | +1.1% | +4.3% |
| UTHR | SELL | 2020-06-29 | 2020-06-30 | $116.81 | $537K | -4.6% | -6.7% | -16.6% |
| UTHR | SELL | 2019-06-27 | 2019-06-28 | $76.11 | $571K | -6.1% | -5.3% | -0.4% |
| UTHR | SELL | 2018-06-29 | 2018-06-29 | $113.07 | $733K | +11.1% | +7.6% | +13.1% |
| UTHR | SELL | 2017-06-23 | 2017-06-23 | $131.71 | $919K | -0.0% | -0.2% | -12.4% |
| UTHR | SELL | 2016-06-02 | 2016-06-03 | $118.82 | $356K | -10.5% | -7.7% | +5.5% |
| UTHR | SELL | 2016-05-12 | 2016-05-13 | $110.00 | $330K | +5.9% | -1.1% | +11.8% |
| UTHR | SELL | 2016-04-01 | 2016-04-04 | $110.81 | $665K | +1.5% | -4.2% | -4.6% |
| UTHR | SELL | 2016-02-04 | 2016-02-04 | $122.67 | $368K | +8.6% | +8.8% | -10.7% |
| UTHR | SELL | 2016-01-07 | 2016-01-07 | $143.53 | $387K | -12.5% | -21.2% | -21.3% |
| UTHR | SELL | 2016-01-07 | 2016-01-07 | $143.45 | $659K | -12.5% | -21.2% | -21.3% |
| UTHR | SELL · 10b5-1 | 2015-12-03 | 2015-12-03 | $157.22 | $472K | -11.9% | +0.8% | -16.4% |
| UTHR | SELL · 10b5-1 | 2015-11-05 | 2015-11-06 | $149.63 | $449K | -11.9% | +0.8% | -20.4% |
| UTHR | SELL · 10b5-1 | 2015-10-01 | 2015-10-01 | $131.32 | $394K | -11.9% | +0.8% | +0.8% |
| UTHR | SELL · 10b5-1 | 2015-09-03 | 2015-09-03 | $155.54 | $467K | -11.9% | +0.8% | +0.8% |
| UTHR | SELL | 2015-08-06 | 2016-06-10 | $166.33 | $998K | -6.9% | -0.7% | +12.1% |
| UTHR | SELL · 10b5-1 | 2015-07-02 | 2015-07-02 | $171.59 | $515K | -11.9% | +0.8% | +0.8% |
| UTHR | SELL · 10b5-1 | 2015-06-04 | 2015-06-04 | $181.37 | $544K | -11.9% | +0.8% | +0.8% |
| UTHR | SELL · 10b5-1 | 2015-05-01 | 2015-05-01 | $159.58 | $479K | -11.9% | +0.8% | +0.8% |
| UTHR | SELL · 10b5-1 | 2015-04-02 | 2015-04-03 | $175.49 | $526K | -11.9% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.